Kohjin Bio, Apr-Jun (1Q) Ordinary Profit Decreases by 48%

About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.

Thu Aug 14, 2025 3:30 pm JST Earnings

177A Kohjin Bio Co.,Ltd. 【J-GAAP】

Earnings Report

Kohjin Bio Co.,Ltd. <177A> [TSE Growth] announced its financial results after the market closed on August 14th (15:30). The consolidated ordinary profit for the first quarter of the fiscal year ending March 2026 (April to June) dropped 48.4% from the same period last year to 0.11 billion yen. Progress toward the full-year plan of 1.13 billion yen was 10.2%, also falling below the same period of the previous year of 21.1%.

In the most recent three-month period, from April to June (1Q), the operating profit margin significantly dropped from 16.6% in the same period last year to 10.7%.

Kabutan News

Actual Results

Accumulated Results 1st Quarter

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Progress Rate vs. First Half	Announce	Accounting Standards
Apr - Jun, 2024	1,241	206	225	162	33.6	54.1	Aug 14, 2024	J-GAAP
Apr - Jun, 2025	1,219	131	116	82	16.1	ー	Aug 14, 2025	J-GAAP
YoY	-1.8%	-36.4%	-48.4%	-49.4%	-52.1%

Current Period Guidance

H1 Results

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Apr - Sep, 2024	2,507	379	416	277	55.7	0	Nov 14, 2024	J-GAAP
Apr - Sep, 2025 Guidance	ー	ー	ー	ー	－	0	May 14, 2025	J-GAAP
YoY	－	－	－	－	－

Current Period Guidance

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Mar, 2024	4,770	596	635	384	92.4	14	May 15, 2024	J-GAAP
Mar, 2025	5,206	991	1,065	794	157.6	24	May 14, 2025	J-GAAP
Mar, 2026 Guidance	5,679	1,065	1,135	822	160.8	25	May 14, 2025	J-GAAP
YoY	+9.1%	+7.5%	+6.6%	+3.5%	+2.1%

Quarterly Results

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Operating Profit Margin	Announce	Accounting Standards
Apr - Jun, 2024	1,241	206	225	162	33.6	16.6	Aug 14, 2024	J-GAAP
Jul - Sep, 2024	1,266	173	191	115	23.1	13.7	Nov 14, 2024	J-GAAP
Oct - Dec, 2024	1,416	296	324	239	47.7	20.9	Feb 14, 2025	J-GAAP
Jan - Mar, 2025	1,283	316	325	278	55.2	24.6	May 14, 2025	J-GAAP
Apr - Jun, 2025	1,219	131	116	82	16.1	10.7	Aug 14, 2025	J-GAAP
YoY	-1.8%	-36.4%	-48.4%	-49.4%	-52.1%